Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
media in order to identify predictive markers. Of note, we are focusing on human embryos since results clearly show that molecular differences with mouse or stem cell models call for more work on human
-
organoids derived from human induced pluripotent stem cells (hiPSCs). The Meng lab integrates brain organoid models with CRISPR-Cas9-based genetic screening, antisense oligonucleotide (ASO)-mediated mRNA
-
to integrate immunology, stem cell technology, and Parkinson’s biology. Supervise junior colleagues, contribute to grant writing, and disseminate findings through high-impact publications. Requirements PhD in
-
Studentships commence: 1st October 2026 Good luck! References 1. Fabrication of topographically controlled electrospun scaffolds to mimic the stem cell microenvironment in the dermal-epidermal junction, ACS
-
requires extensive experience with cardiovascular and neurological studies and basic stem cell research. MINIMUM QUALIFICATIONS This position requires a PhD from an accredited college or university in
-
an Associate Researcher to join a project aimed at identifying new target molecules (receptors) on leukemia stem cells, characterizing their function, and developing antibodies directed against these targets
-
environmental and hormonal control of plant stem cell differentiation. You should be proficient in bulk and single-cell RNA-seq, ChIP-seq, and/or ATAC-seq analyses and standard bioinformatics pipelines
-
The Laboratory of Cortical Information Processing | Vision to Action at NERF (www.nerf.be ) invites applications for a Postdoctoral Fellow or PhD Student to work on a new research project funded by
-
METABOLIC REGULATION OF GENOME FUNCTION AND CELL IDENTITY WITH RELEVANCE TO STEM CELL BIOLOGY AND CANCER NUCLEAR will train 17 Doctoral candidates (DC) in the emerging field of Metabolic Regulation of Genome
-
of patient-derived primary glioma stem cell-like (GSC) culture models, and conducting detailed efficacy studies assessing DNA repair inhibitors in combination with TTFields and standard of care therapies in